Concepedia

Jeffrey Riskin

JR

Statistics

Publications

2

Citations

154

H-Index

2

Active since

2017

Affiliations

Ono Pharmaceutical (United States)(Current)

Jeffrey Riskin is an author at Ono Pharmaceutical (United States) specializing in medicine, oncology, and tumor microenvironment-mediated resistance.

Publications per year

2017–2020

2

Publications

2

Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

Lucas A. Horn, Jeffrey Riskin, Heidi Hempel et al. · Journal for ImmunoTherapy of Cancer · 2020 · 96 citations · Full text

, , +17

Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats

Xiyuan Zhang, Katherine L. Cook, Anni Wärri et al. · Clinical Cancer Research · 2017 · 58 citations · Full text

, , +11

1–2 of 2